A method and apparatus is provided for non-surgical reversible sterilization of females. In the method of this invention an apparatus to which a removable tip is attached is inserted into the uterus. The tip is aligned with the uterine end of the oviduct. A curable elastomeric composition is injected, through an aperture in the tip, into the oviduct in an amount sufficient to fill the portion of the oviduct adjacent to the uterus. The elastomeric composition is allowed to solidify and adhere to the above noted tip. The apparatus is then removed with the tip being ejected from the apparatus so as to remain adhered to the resulting oviduct block. The above procedure is repeated for the opposite oviduct. The resulting oviduct blocks prevent the passage of ovum from the ovaries to the uterus and sperm from entering the oviduct thereby preventing conception. The oviduct blocks if desired can be removed non-surgically by utilizing an apparatus which grips the tip portion of the oviduct block and extracts the entire oviduct block from the oviduct.
|
15. A non-surgically removable oviduct block for a female, comprising: a solid body of solidified plastic material having a transverse dimension conforming to the interior of the oviduct and having at one end a solid molded tip portion with a configuration adapted to fit in contact with the uterine end of the oviduct of said female forming a single unit; said molded tip portion having a transverse dimension larger than the interior of the oviduct to prevent said block from migrating into the intraperitoneal cavity, whereby said tip portion remains accessible from the uterine cavity, said molded tip portion having means thereon which can be gripped by mechanical means to remove the oviduct block non-surgically; said body of plastic material having a length providing a volume sufficient to block the passage of ovum through said oviduct to the uterine cavity of said female.
28. The method of forming non-surgically removable oviduct block in a female, comprising the steps of:
a. introducing an injecting means through the cervical os into the uterine cavity of said female; b. positioning the injecting means adjacent the uterine end of the oviduct and providing a seal with the uterine wall in the marginal area circumscribing the interior of the oviduct limiting the flow into the uterine cavity of material dispensed by the injecting means; c. injecting from said injecting means into the interior of said oviduct beyond said seal a plastic material which will flow into engagement with said seal, said plastic material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity; and d. allowing said plastic material to solidify in said oviduct and provide an oviduct block at least partially formed by said solidified plastic material, whereby the block can be gripped by mechanical means to remove the oviduct block non-surgically.
22. The method of forming non-surgically removable oviduct block in a female, comprising the steps of:
a. introducing an injecting means through the cervical os into the uterine cavity of said female; b. providing a seal between said injecting means and the wall of the uterus in the marginal area circumscribing the uterine end of the oviduct of said female to limit the flow into the cavity of material dispensed by the injecting means; c. injecting from said injecting means into the interior of said oviduct beyond said seal a plastic material which will flow into engagement with said seal, said plastic material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity; and d. allowing said plastic material to solidify in said oviduct and provide an oviduct block at least partially formed by said solidified plastic material and having a tip portion larger than the interior of the end of said oviduct exposed in the uterine cavity, whereby the exposed portion of the block can be gripped by mechanical means to remove the oviduct block non-surgically.
21. The method of forming non-surgically removable oviduct block in a female, comprising the steps of:
a. introducing an injecting means through the cervical os into the uterine cavity of said female; b. providing a pre-formed tip member having an aperture therein adjacent to the uterine end of the oviduct of said female to limit the flow of material dispensed by the injecting means; c. injecting from said injecting means through said aperture into the interior of said oviduct beyond said tip member a plastic material which will flow into engagement with said tip member, said plastic material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity; and d. allowing said plastic material to solidify in said oviduct in contact with said tip member to provide a single-unit oviduct block at least partially formed by said solidified plastic material, said tip member providing a portion larger than the interior of the end of said oviduct exposed in the uterine cavity, whereby the exposed portion of the block can be gripped by mechanical means to remove the oviduct block non-surgically.
10. Apparatus for forming an oviduct block comprising: a tubular means having a length sufficient to extend from the vagina area of a female to the uterine end of the oviduct and having a diameter sufficiently small to pass longitudinally through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end having means to engage and connect a tip member thereto, said tubular means including means therein for adjustably displacing said first terminal end laterally relative to said second terminal end to position said first terminal end adjacent the uterine end of said oviduct to cause the tip member to at least temporarily block said uterine end; said tubular means further including fluid passage means for transmission of a plastic material from a point adjacent to the second terminal end into said oviduct beyond said tip member at first terminal end of said tubular means, and means to dispense a sufficient amount of said material to fill a predetermined length of the oviduct and to flow into engagement with the tip member at the uterine end of said oviduct, to form a block having an enlarged end portion exposed in the uterine end of the oviduct.
1. The method of forming non-surgically removable oviduct block in a female comprising the step of
a. providing a shaped tip member having an aperture defined therein; said tip member having a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of said female, and having a size larger than the lumen of said oviduct; said tip member being formed from a given cured elastomeric material b. positioning said tip member within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct c. injecting through the aperture of said tip member into the lumen of said oviduct a mixture of a fluid self curing elastomeric material which will solidify in said oviduct and adhere to said tip member, said elastomeric material being injected into said oviduct in an amount sufficient to block the passage of ovum through said oviduct to the uterine cavity d. and thereafter allowing said uncured elastomeric material to cure to a solidified mass while in contact with said tip member, whereby an oviduct block is formed wherein the tip member remains within the uterine cavity where it can be gripped by mechanical means to remove the oviduct block non-surgically.
14. Apparatus for forming an oviduct block comprising: a tubular means having a length sufficient to extend from the vagina area of a female to the uterine end of the oviduct and having a diameter sufficiently small to pass through the cervix of said female; said tubular means having first and second terminal ends; said first terminal end including means for holding and releasing a tip member, said tubular means including means for positioning said first terminal end with said tip member thereon adjacent the uterine end of said oviduct to at least temporarily block said uterine end; said tubular means further including fluid passage means for transmission of a plastic material from a point adjacent to the second terminal end into said oviduct beyond said tip member at first terminal end of said tubular means, and means to dispense a sufficient amount of said material to fill a predetermined length of the oviduct and to flow into engagement with the tip member at the uterine end of said oviduct, to form a block having an enlarged end portion exposed in the uterine end of the oviduct, said holding and releasing means comprising a slidable member positioned within said tubular means, whereby when the tip member is held at the first terminal end by said slidable member and said slidable member is drawn through said tubular means toward the second terminal end, said tip member is released from said slidable member.
2. The method according to
3. The method according to
4. The method according to
5. The apparatus for forming the oviduct block according to
7. The apparatus according to
8. The apparatus according to
9. The apparatus according to
11. The apparatus of
12. The apparatus according to
13. The apparatus according to
16. The oviduct block of
17. The oviduct block of
18. The oviduct block of
19. The oviduct block of
20. The oviduct block of
23. The method according to
24. The method according to
25. The method of
26. The method of
27. The method of
29. The method of
|
The invention described herein was reduced to practice in the course of work under a grant or award from the Department of Health, Education and Welfare.
1. Field of the Invention
This invention is concerned with a method and apparatus for non-surgical, reversible sterilization of females.
2. Description of the Prior Art
One of the more pressing problems which is encountered in the World today is that of over population. The problem of over population which has been a substantial problem for a considerable period of time in certain highly populated areas, such as Asia and the Indian Sub-Continent is now becoming a problem in less populated areas of the World such as Europe and the Americas. Over population results in such long range problems as pollution, famine and even war.
Birth control has been relied on as the principal means to control over population. In the field of birth control the prevention of conception is considerably more acceptable for controlling population growth than abortion. However, the methods heretofore suggested for contraception have had certain inherent problems which limited the applicability and effectiveness.
The ideal contraception method should be 100 percent effective in preventing conception; should not rely on willpower; should not interfere with the satisfaction of sexual relationships, and should be low in cost taking into consideration the effective life of the contraceptive method. In addition the contraceptive method must not have any harmful psychological side effects. An extremely important feature of an ideal contraceptive method especially for family planning is that it be reversible so that it will be possible to have additional children if desired.
The most common methods of contraception which are currently employed on a mass scale each have certain inherent deficiencies which limit their usefulness. The use of such techniques and devices such as rhythm, withdrawal, condoms and diaphragms and vaginal foams all have been found to be highly unreliable. The more recently promoted methods such as intrauterine devices and use of contraceptive pills likewise have certain defects which limit their effectiveness. The intrauterine devices cannot be utilized by all females and there is some indication that they cause irritation and discomfort and are often rejected by females. The contraceptive pill cannot be utilized by many females due to incompatability with their normal hormone balance. Furthermore, the use of the pill has been found to increase the risks of certain desires desired.
A tip 10 is molded from an inert plastic material to which the injected elastomeric material will adhere on solidification. In this regard it should be noted that silicone-rubber is ideally suited for this purpose when a silicone elastomer is used for formation of the oviduct block.
As shown in the drawing the portion of the tip 10 which will be in contact with uterine end of the oviduct 12 has a spherical configuration. The tip 10 has an aperture 14 which extends throughout the entire length of the tip 14 10. In addition the tip as illustrated has a series of annular piston rings 16 molded into the interior portion surface of the aperture 14. The tip 10 further includes a loop 18 which is preferably a thread of a material which is inert in uterine fluids, such as nylon.
The apparatus 20 shown in FIG. 1 is specifically designed for use in the method of this invention. The apparatus 20 includes a tubular extension 22, a dispensing apparatus 24, and a control handle 26 for both operating the dispensing means and positioning the tip 10 on the end of the tubular extension 22.
The tubular extension 22 has a rigid section which is adjacent to the control handle 26. The opposite terminal end portion 28 on which the tip 10 is secured is flexible. One end of each control wire 30, 32 is attached to the end portion of the flexible section 28. The control wires 30, 32 are connected at their opposite ends to a pair of separately controlled drums 34 (only one drum is shown) mounted on the control hand handle 26. By adjustment of the drums 34 to either to collect or release the wires 30, 32 the position of the tip 10 can be adjusted and bent in a curved configuration shown in FIG. 2.
At the flexible terminal end 28 a metal connector 36 is provided which has annular piston ring rings 38 which mates mate with the piston rings 16 on the tip 10. The metal connector 36 further has defined in it a constricted area having a sharp cut off portion 40.
A tube 42 extends from the dispensing means 24, through the tubular extension 22 to the aperture 14 in the tip 10.
The dispensing means 24 consists of a mixing syringe 44 in which the plunger 46 is adapted to provide mixing of a fluid elastermeric material, a catalyst and other additive as may be required. The syringe 44 is mounted on top of the control handle 26 with the plunger 46 in contact with a rack 48 and a pivotal mounted pawl 50. The pawl 50 is connected to a trigger 52. Squeezing the trigger 52 causes the plunger 46 to be advanced within the syringe 46 44 and material within the syringe 44 to be dispensed through the tube 42 to the tip 10.
In the method of this invention the tip 10 is inserted over the end of the flexible portion 28 of the tubular extension. The tip 10 being premolded of a silicone rubber is somewhat elastic and deforms somewhat until the piston ring 16 of the tip of 10 engages and locks with the mating piston rings 38.
The tubular extension 20 22 with tip 10 installed is inserted into the vagina 54, through the cervical os 56 into the uterine cavity 58. Then, preferably using flouroscopic fluoroscopic techniques, the tip 10 is aligned with the uterine end of one of the oviducts 12. It should be noted that because of the shape of the uterine cavity 58 the tip can be guided blindly in the proper position. The relative position of the flexible end 28 is controlled by adjustment of the drums 34.
Once the tip 10 is in position the fluid mixture of the elastomer, catalyst and other additives are injected through the tube 42 to the tip 10 by operation of the trigger 52 as noted above. The uncured fluid elastomeric mixture 60 flows through the aperture 14 in the tip 10 and then into the oviduct 12. A sufficient amount of the mixture is injected to fill approximately one third or more of the length of the oviduct 12. Some of the material will flow back around the tip 10 so that the surface of the tip 10 will conform to the shape of the uterine end of the oviduct 12 as shown in the tip 10 as modified 62 which is shown in FIG. 5.
The injected elastomeric material 60 is allowed to cure and solidify. The cured material will adhere to the tip 10 to make an essential single unit.
Once the elastomeric material has cured, the tube 40 42 and the terminal end 36 28 are withdrawn within the tubular extension 22. The edge 40 cuts the cured material which remains in the tube 42 from the cured material in the aperture 14 of the tip 10. Continued withdrawal of the terminal end 36 28 results in the tip 10 being stripped from the terminal end as shown in phantom in FIG. 5.
The procedure noted above is repeated for the opposite oviduct to complete the sterilization procedure.
The solidified oviduct blocks each has a configuration which conforms to the interior of the oviduct in which it is cast, thus effectively preventing conception.
The shaped tip member has an aperture defined therein and a configuration such as to fit in substantial sealing contact adjacent to the uterine end of the oviduct of the female. It has a size larger than the lumen of said oviduct and is positioned within the uterine cavity of said female adjacent to the uterine end of said oviduct with the aperture of said tip member being in axial alignment with the lumen of said oviduct, whereby the tip member remains within the uterine cavity where it can be gripped by mechanical means to remove the oviduct block nonsurgically.
The oviduct block can remain in place until it is desired to remove it. The use of a material having approximately the same modulus of elasticity as the oviducts assists in maintaining the oviduct blocks 64 in position. The natural convolution of the oviduct likewise results in stabilization of the oviduct blocks 64. The tip 10 serves a most important function of preventing the oviduct block 64 from migrating into the intraperitoneal cavity, a problem that was a serious and relatively common problem with other similar prior art technique techniques .
As noted above the oviduct block is inserted nonsurgically. The method is relatively simple to learn by those skilled in the medical art. The time required is likewise quite short with a skilled person being able to block both oviducts in about 15 to 30 minutes.
As noted above the oviduct block can be removed nonsurgically if desired. An instrument of the type shown in FIG. 1 is used for this purpose. The tip 10 is replaced with a hooked member which is adapted to engage the loop 18. Once the loop 18 is engaged the oviduct block 64 is withdrawn. It is also possible to use a pronged member to grip the tip and then pull out the oviduct block.
Both the insertion and removal of the oviduct block 64 are relatively painless. However a local anesthetic can be used if desired.
The effectivenes of the contraception method of this invention was found to be excellent. On rabbit tests it was found that the method is 100% effective if the oviduct blocks are properly placed. In further rabbit tests it was found that after the oviduct blocks were removed that fertility was restored. There was no indication of expulsion of the oviduct blocks either in the uterine cavity or in the intraperitoneal cavity. Histologic examination and scanning election microscopic examination have not indicated that there is any adverse reaction to the tissue of the oviducts.
The apparatus of this invention has been described in the preferred embodiment. It should be appreciated that the various modifications can be made to the apparatus without departing from the scope of this invention. For example, the control handle 26 has been provided to enable a simple one handed operation of the apparatus. If It is possible, however, to simply use control wires which are operated by the fingers of the hand rather than the drums. Further, the dispensing apparatus consisting of the trigger 52, rack 48 and pawl 50, could likewise be removed and the syringe operated manually. Furthermore, the configuration of the tip 10 can be modified to a different shape such as a conical configuration of or other suitable shapes and still be satisfactory for use in this invention. These and other modifications which would be obvious to those skilled in the art are included within the scope of the subjoined claims.
Patent | Priority | Assignee | Title |
10070888, | Oct 03 2008 | FEMASYS INC | Methods and devices for sonographic imaging |
10111687, | Feb 25 2004 | Femasys, Inc. | Methods and devices for conduit occlusion |
10172643, | Oct 03 2008 | Femasys, Inc. | Contrast agent generation and injection system for sonographic imaging |
10258375, | Oct 03 2008 | Femasys, Inc. | Methods and devices for sonographic imaging |
10292732, | Feb 25 2004 | Femasys, Inc. | Methods and devices for conduit occlusion |
11154326, | Oct 03 2008 | Femasys Inc. | Methods and devices for sonographic imaging |
11648033, | Oct 03 2008 | Femasys Inc. | Methods and devices for sonographic imaging |
11779372, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
4446578, | Mar 08 1982 | Joint treatment | |
4606336, | Nov 23 1984 | Method and apparatus for non-surgically sterilizing female reproductive organs | |
4834091, | Apr 10 1987 | Intrauterine fallopian tube ostial plug and surgical process | |
5888220, | May 06 1994 | DISC DYNAMICS, INC | Articulating joint repair |
5954715, | Jun 05 1997 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
5979446, | Oct 22 1998 | Synergyn Technologies, Inc. | Removable fallopian tube plug and associated methods |
6068626, | Jun 05 1997 | Cytyc Corporation | Method and apparatus for tubal occlusion |
6145505, | Jun 07 1995 | BAYER ESSURE INC | Electrically affixed transcervical fallopian tube occlusion devices |
6176240, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
6248131, | May 06 1994 | DISC DYNAMICS, INC | Articulating joint repair |
6346102, | Jun 05 1997 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
6357443, | Oct 22 1998 | Synergyn Technologies, Inc. | Removable fallopian tube plug and associated methods |
6526979, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and methods |
6634361, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and methods |
6679266, | Jun 07 1995 | Bayer HealthCare LLC | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
6684884, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and methods |
6705323, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and methods |
6709667, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system for intrafallopian contraception |
6712810, | Feb 01 1999 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
6726682, | Jun 05 1997 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
6763833, | Aug 23 1999 | Bayer HealthCare LLC | Insertion/deployment catheter system for intrafallopian contraception |
7001431, | May 06 1994 | DISC DYNAMICS, INC | Intervertebral disc prosthesis |
7077865, | May 06 1994 | DISC DYNAMICS, INC | Method of making an intervertebral disc prosthesis |
7220259, | Jun 05 1997 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
7237552, | Aug 23 1999 | Bayer HealthCare LLC | Insertion/deployment catheter system for intrafallopian contraception |
7428904, | Jun 07 1995 | Bayer HealthCare LLC | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
7506650, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system for intrafallopian contraception |
7582085, | May 23 2002 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Catheter placement detection system and operator interface |
7591268, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system for intrafallopian contraception |
7686020, | Jun 07 1995 | Bayer HealthCare LLC | Contraceptive transcervical fallopian tube occlusion devices and methods |
7713301, | May 06 1994 | Disc Dynamics, Inc. | Intervertebral disc prosthesis |
7766965, | May 06 1994 | Disc Dynamics, Inc. | Method of making an intervertebral disc prosthesis |
7842035, | Feb 01 1999 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
7905880, | Jun 05 1997 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Method and apparatus for tubal occlusion |
7921848, | Jun 07 1995 | Bayer HealthCare LLC | Contraceptive transcervical fallopian tube occlusion devices and methods |
7934504, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system for intrafallopian contraception |
8048086, | Feb 25 2004 | Femasys Inc.; FEMASYS INC | Methods and devices for conduit occlusion |
8048101, | Feb 25 2004 | FEMASYS INC | Methods and devices for conduit occlusion |
8052669, | Feb 25 2004 | FEMASYS INC | Methods and devices for delivery of compositions to conduits |
8066007, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
8079364, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system for intrafallopian contraception |
8171936, | Jun 07 1995 | BAYER ESSURE INC | Contraceptive transcervical fallopian tube occlusion devices and methods |
8217219, | Dec 29 2003 | Kimberly-Clark Worldwide, Inc | Anatomically conforming vaginal insert |
8226645, | Feb 01 1999 | Cytyc Corporation | Apparatus for tubal occlusion |
8231619, | Jan 22 2010 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Sterilization device and method |
8316853, | Feb 25 2004 | Femasys Inc. | Method and devices for conduit occlusion |
8316854, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
8324193, | Feb 25 2004 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
8327852, | Jun 07 1995 | BAYER ESSURE INC | Occlusion devices and methods |
8336552, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
8356599, | Sep 24 1997 | Bayer HealthCare LLC | Occlusion devices and methods |
8381733, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system |
8506543, | Dec 29 2003 | Kimberly-Clark Worldwide, Inc | Anatomically conforming vaginal insert |
8550086, | May 04 2010 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Radiopaque implant |
8584679, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system |
8613282, | Sep 24 1997 | Bayer HealthCare LLC | Occlusion devices and methods |
8695604, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system |
8695606, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
8702727, | Feb 01 1999 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Delivery catheter with implant ejection mechanism |
8726906, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
8733360, | Sep 24 1997 | Bayer HealthCare LLC | Occlusion devices and methods |
8733361, | Jun 07 1995 | BAYER ESSURE INC | Occlusion devices and methods |
9034053, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
9220880, | Feb 25 2004 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
9238127, | Feb 25 2004 | FEMASYS INC | Methods and devices for delivering to conduit |
9308023, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
9402762, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
9492291, | May 01 2008 | KUNOVUS PTY LTD | Systems, methods and apparatuses for formation and insertion of tissue prosthesis |
9554826, | Oct 03 2008 | FEMASYS INC | Contrast agent injection system for sonographic imaging |
9597224, | Aug 23 1999 | Bayer HealthCare LLC | Deployment actuation system |
9839444, | Feb 25 2004 | Femasys Inc. | Methods and devices for conduit occlusion |
Patent | Priority | Assignee | Title |
3042021, | |||
3182662, | |||
3422813, | |||
3648683, | |||
3680542, | |||
3707146, | |||
3918443, | |||
854399, | |||
FR819,629, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 22 1976 | The Franklin Institute | (assignment on the face of the patent) | / | |||
Jan 09 1985 | Franklin Institute | Calspan Corporation | ASSIGNMENT OF ASSIGNORS INTEREST | 004379 | /0744 | |
Jun 04 1986 | CALSPAN CORPORATION, AN OH CORP | Franklin Institute | ASSIGNMENT OF ASSIGNORS INTEREST | 004747 | /0260 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Aug 09 1980 | 4 years fee payment window open |
Feb 09 1981 | 6 months grace period start (w surcharge) |
Aug 09 1981 | patent expiry (for year 4) |
Aug 09 1983 | 2 years to revive unintentionally abandoned end. (for year 4) |
Aug 09 1984 | 8 years fee payment window open |
Feb 09 1985 | 6 months grace period start (w surcharge) |
Aug 09 1985 | patent expiry (for year 8) |
Aug 09 1987 | 2 years to revive unintentionally abandoned end. (for year 8) |
Aug 09 1988 | 12 years fee payment window open |
Feb 09 1989 | 6 months grace period start (w surcharge) |
Aug 09 1989 | patent expiry (for year 12) |
Aug 09 1991 | 2 years to revive unintentionally abandoned end. (for year 12) |